Literature DB >> 26339875

[High frequency of thyroid abnormalities in polycystic ovary syndrome].

Cecilia E Calvar1, Sonia V Bengolea, Susana I Deutsch, Ricardo Hermes, Gustavo Ramos, Marcelo Loyato.   

Abstract

The prevalence of thyroid abnormalities (TA) has not been sufficiently assessed in polycystic ovary syndrome (PCOS). Our aim was to evaluate this relationship. In this prospective study 194 women were included. The PCOS group consisted of 142 patients (diagnosed by Rotterdam 2003 criteria) and the control group included 52 age-matched healthy women. Fasting blood samples were drawn for free T4, thyrotropin, thyroperoxidase antibodies (TPOAb), fasting insulin, glucose and HOMA-IR were calculated. A total of 52 PCOS patients had either autoimmune thyroiditis (AIT+) and/or subclinical hypothyroidism (HSC) (36.6%) (thyroid abnormalities:TA+) compared with 7 women of the control group (13.5%), accounting for more than a five fold higher prevalence of TA in PCOS patients, compared with the age-matched controls (adjusted odds ratio: 5.6; CI 95%: 2.1 -14.9; p<0.001). TA+ patients had significantly higher FI and HOMA-IR values than patients without thyroid abnormalities (p<0.05). These results demonstrate a high rate of TA in young PCOS women, associated with higher levels of FI and HOMA-IR. As PCOS, hypothyroidism and thyroid autoimmunity may have a profound impact on reproductive health, our data indicate that PCOS patients should be screened for TA.

Entities:  

Keywords:  autoimmune thyroiditis; hypothyroidism; polycystic ovary syndrome

Mesh:

Substances:

Year:  2015        PMID: 26339875

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  7 in total

1.  ANTI-THYROID ANTIBODIES AND THE GONADOTROPHINS PROFILE (LH/FSH) IN EUTHYROID POLYCYSTIC OVARIAN SYNDROME WOMEN.

Authors:  M Sharma; A Modi; M Goyal; P Sharma; P Purohit
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

2.  Hashimoto's thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels.

Authors:  Aliye Nigar Serin; Özer Birge; Aysel Uysal; Süheyla Görar; Feyza Tekeli
Journal:  BMC Endocr Disord       Date:  2021-03-09       Impact factor: 2.763

3.  Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome.

Authors:  Melia Karaköse; Sema Hepsen; Erman Çakal; Müyesser Saykı Arslan; Esra Tutal; Şafak Akın; İlknur Ünsal; Mustafa Özbek
Journal:  J Turk Ger Gynecol Assoc       Date:  2017-02-07

4.  Subclinical Hypothyroidism in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Xiaohong Ding; Lili Yang; Jian Wang; Rong Tang; Qianqian Chen; Jiexue Pan; Haiyan Yang; Xia Chen; Zimiao Chen; Liangshan Mu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-27       Impact factor: 5.555

Review 5.  Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto's Thyroiditis: How Far Is Our Understanding?

Authors:  Natalia Zeber-Lubecka; Ewa E Hennig
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

6.  Association between PCOS and autoimmune thyroid disease: a systematic review and meta-analysis.

Authors:  Mirian Romitti; Vitor C Fabris; Patricia K Ziegelmann; Ana Luiza Maia; Poli Mara Spritzer
Journal:  Endocr Connect       Date:  2018-10-26       Impact factor: 3.335

7.  The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome

Authors:  Sema Hepşen; Melia Karaköse; Erman Çakal; Sanem Öztekin; İlknur Ünsal; Pınar Akhanlı; Bekir Uçan; Mustafa Özbek
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-04-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.